INS and Hyperglycemia: Furthermore, Assaloni et al. [80] reported that administration of mitiglinde, a fast-acting, short-duration, insulin secretagogue, resulted in stimulation of insulin secretion and reduction of postprandial hyperglycemia in T2DM patients.